- Home
- LINC vs VRCA Comparison
LINC vs VRCA Comparison
Compare LINC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINC
- VRCA
- Stock Information
- Founded
- LINC 1946
- VRCA 2013
- Country
- LINC United States
- VRCA United States
- Employees
- LINC N/A
- VRCA N/A
- Industry
- LINC Other Consumer Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- LINC Real Estate
- VRCA Health Care
- Exchange
- LINC Nasdaq
- VRCA Nasdaq
- Market Cap
- LINC 426.1M
- VRCA 363.1M
- IPO Year
- LINC 2005
- VRCA 2018
- Fundamental
- Price
- LINC $15.60
- VRCA $0.99
- Analyst Decision
- LINC Strong Buy
- VRCA Buy
- Analyst Count
- LINC 4
- VRCA 6
- Target Price
- LINC $18.00
- VRCA $7.33
- AVG Volume (30 Days)
- LINC 120.5K
- VRCA 771.3K
- Earning Date
- LINC 11-11-2024
- VRCA 11-04-2024
- Dividend Yield
- LINC N/A
- VRCA N/A
- EPS Growth
- LINC N/A
- VRCA N/A
- EPS
- LINC 0.32
- VRCA N/A
- Revenue
- LINC $423,213,000.00
- VRCA $9,210,000.00
- Revenue This Year
- LINC $15.35
- VRCA $123.42
- Revenue Next Year
- LINC $9.30
- VRCA $124.76
- P/E Ratio
- LINC $48.08
- VRCA N/A
- Revenue Growth
- LINC 15.21
- VRCA 187.45
- 52 Week Low
- LINC $8.78
- VRCA $0.70
- 52 Week High
- LINC $18.74
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- LINC 63.07
- VRCA 42.49
- Support Level
- LINC $14.82
- VRCA $0.80
- Resistance Level
- LINC $18.74
- VRCA $0.94
- Average True Range (ATR)
- LINC 0.86
- VRCA 0.12
- MACD
- LINC -0.05
- VRCA 0.02
- Stochastic Oscillator
- LINC 41.74
- VRCA 34.42
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services and business and information technology. Its reportable segments include; Campus Operations, and Transitional. Majority of the revenue is generated from Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.